Breakthrough Lipid Nanoparticle Technology
Next-Generation Gene Therapy
Common Cell Transfection
Universal transfection for multiple RNAs and multiple cell types, suitable for all experimental scenarios
Immune Cell Transfection
Overcome the challenges in the delivery of immune cells, achieving both excellent activity and high efficiency.
In Vivo Transfection
It covers a full range from broad-spectrum to targeted delivery, breaking through the limits of in vivo transfection.
Gene Editing
Breakthroughs in both CRISPR and LNP fronts enable precise editing of immune cells and conventional cells.

Scindy Pharmaceutical (Suzhou) Co., Ltd.

Address: 6 / F, Block B, Building 4, No. 108 Yuxin Road, Suzhou Industrial Park, Suzhou, Jiangsu, P.R.China

Zip Code: 215125

Tel: +86 (512) 8886-5668

Email: service@scindypharm.com (For Sales)

Email: BD@scindypharm.com (For Cooperation)

【WeChat】
【Official Account】
Copyright © 2023 Scindy Pharmaceutical (Suzhou) Co., Ltd.        ICP NO.: 苏ICP备2021045264号-1